HEADER ANTITUMOR PROTEIN 23-FEB-05 1YY2 TITLE NMR CONFORMATIONAL ANALYSIS OF LHRH AND ITS ANALOGUES COMPND MOL_ID: 1; COMPND 2 MOLECULE: LEUPROLIDE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 4 ORGANISM_TAXID: 32630; SOURCE 5 OTHER_DETAILS: MODIFIED SEQUENCE OF LHRH KEYWDS U-SHAPE LIKE PEPTIDE, ANTITUMOR PROTEIN EXPDTA SOLUTION NMR NUMMDL 21 MDLTYP MINIMIZED AVERAGE AUTHOR G.A.SPYROULIAS,A.ZOMPRA,V.MAGAFA,P.CORDOPATIS REVDAT 6 23-OCT-24 1YY2 1 LINK REVDAT 5 01-MAR-23 1YY2 1 COMPND SOURCE REMARK DBREF REVDAT 5 2 1 SEQRES LINK ATOM REVDAT 4 25-DEC-19 1YY2 1 SOURCE REMARK SEQRES LINK REVDAT 3 24-FEB-09 1YY2 1 VERSN REVDAT 2 07-MAR-06 1YY2 1 SEQRES FORMUL LINK TER REVDAT 2 2 1 CONECT REVDAT 1 21-FEB-06 1YY2 0 JRNL AUTH G.A.SPYROULIAS,A.ZOMPRA,V.MAGAFA,P.CORDOPATIS JRNL TITL NMR CONFORMATIONAL ANALYSIS OF LHRH AND ITS ANALOGUES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 3.1, AMBER 5.0 REMARK 3 AUTHORS : BRUKER (XWINNMR), D.A.PEARLMAN, D.A.CASE, REMARK 3 W.CALDWELL, W.S.ROSS, T.E.CHEATHAM, D.M.FERGUSON, REMARK 3 G.L.SEIBEL, U.C.SINGH, P.K.WEINER, P.A.KOLLMAN REMARK 3 (AMBER) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE MODELS HAVE BEEN DETERMINED USING REMARK 3 135 NOE-DERIVED DISTANCE CONSTRAINTS REMARK 4 REMARK 4 1YY2 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 25-FEB-05. REMARK 100 THE DEPOSITION ID IS D_1000032056. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.0MM-3.0MM REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; 2D NOESY; 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ REMARK 210 SPECTROMETER MODEL : DPX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.1, XEASY 1.3, DYANA REMARK 210 1.5 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 400 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 2 -86.86 -145.16 REMARK 500 1 TRP A 3 -158.83 -176.81 REMARK 500 1 SER A 4 111.05 92.71 REMARK 500 1 TYR A 5 21.43 -79.75 REMARK 500 2 HIS A 2 -88.73 -137.14 REMARK 500 2 TRP A 3 -155.79 -176.43 REMARK 500 2 SER A 4 107.57 94.13 REMARK 500 2 TYR A 5 20.28 -78.67 REMARK 500 3 HIS A 2 -88.08 -123.96 REMARK 500 3 TRP A 3 -150.05 -174.52 REMARK 500 3 SER A 4 107.79 86.58 REMARK 500 3 TYR A 5 20.10 -78.63 REMARK 500 4 HIS A 2 -88.64 -122.16 REMARK 500 4 TRP A 3 -156.80 -176.62 REMARK 500 4 SER A 4 109.20 93.78 REMARK 500 5 HIS A 2 -88.68 -128.92 REMARK 500 5 TRP A 3 -148.07 -174.27 REMARK 500 5 SER A 4 106.74 78.74 REMARK 500 5 TYR A 5 22.72 -79.29 REMARK 500 6 HIS A 2 -87.79 -142.04 REMARK 500 6 TRP A 3 -157.23 -175.88 REMARK 500 6 SER A 4 109.61 95.51 REMARK 500 6 TYR A 5 20.49 -79.76 REMARK 500 7 HIS A 2 -88.17 -146.09 REMARK 500 7 TRP A 3 -156.14 -176.92 REMARK 500 7 SER A 4 109.17 95.21 REMARK 500 8 HIS A 2 -87.78 -114.33 REMARK 500 8 TRP A 3 -156.32 -176.03 REMARK 500 8 SER A 4 108.70 89.34 REMARK 500 9 HIS A 2 -87.71 -141.72 REMARK 500 9 TRP A 3 -155.26 -175.79 REMARK 500 9 SER A 4 109.28 93.76 REMARK 500 10 HIS A 2 -88.76 -134.31 REMARK 500 10 TRP A 3 -151.22 -174.89 REMARK 500 10 SER A 4 108.00 89.97 REMARK 500 10 TYR A 5 21.64 -79.22 REMARK 500 11 HIS A 2 -88.26 -121.59 REMARK 500 11 TRP A 3 -157.10 -175.67 REMARK 500 11 SER A 4 110.07 96.54 REMARK 500 12 HIS A 2 -87.40 -141.75 REMARK 500 12 TRP A 3 -148.01 -173.96 REMARK 500 12 SER A 4 107.30 84.53 REMARK 500 12 TYR A 5 20.88 -77.56 REMARK 500 13 HIS A 2 -88.57 -142.19 REMARK 500 13 TRP A 3 -155.35 -176.29 REMARK 500 13 SER A 4 110.24 97.62 REMARK 500 14 HIS A 2 -87.94 -142.58 REMARK 500 14 TRP A 3 -156.07 -177.64 REMARK 500 14 SER A 4 109.54 94.91 REMARK 500 14 TYR A 5 21.08 -79.30 REMARK 500 REMARK 500 THIS ENTRY HAS 77 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NEH A 10 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1YY1 RELATED DB: PDB DBREF 1YY2 A 1 10 PDB 1YY2 1YY2 1 10 SEQRES 1 A 10 PCA HIS TRP SER TYR DLE LEU ARG PRO NEH MODRES 1YY2 PCA A 1 GLN PYROGLUTAMIC ACID MODRES 1YY2 DLE A 6 LEU D-LEUCINE HET PCA A 1 14 HET DLE A 6 19 HET NEH A 10 9 HETNAM PCA PYROGLUTAMIC ACID HETNAM DLE D-LEUCINE HETNAM NEH ETHANAMINE FORMUL 1 PCA C5 H7 N O3 FORMUL 1 DLE C6 H13 N O2 FORMUL 1 NEH C2 H7 N LINK C PCA A 1 N HIS A 2 1555 1555 1.33 LINK C TYR A 5 N DLE A 6 1555 1555 1.33 LINK C DLE A 6 N LEU A 7 1555 1555 1.33 LINK C PRO A 9 N NEH A 10 1555 1555 1.34 SITE 1 AC1 4 TRP A 3 SER A 4 ARG A 8 PRO A 9 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 HETATM 1 N PCA A 1 -5.307 1.777 8.665 1.00 0.66 N HETATM 2 CA PCA A 1 -3.947 1.488 8.249 1.00 0.24 C HETATM 3 CB PCA A 1 -3.050 1.900 9.433 1.00 0.79 C HETATM 4 CG PCA A 1 -4.022 2.316 10.545 1.00 1.09 C HETATM 5 CD PCA A 1 -5.387 2.278 9.889 1.00 0.95 C HETATM 6 OE PCA A 1 -6.418 2.661 10.435 1.00 1.43 O HETATM 7 C PCA A 1 -3.783 0.017 7.873 1.00 0.23 C HETATM 8 O PCA A 1 -4.407 -0.858 8.465 1.00 0.53 O HETATM 9 H PCA A 1 -6.116 1.585 8.094 1.00 1.08 H HETATM 10 HA PCA A 1 -3.706 2.109 7.386 1.00 0.61 H HETATM 11 HB2 PCA A 1 -2.432 2.752 9.145 1.00 1.05 H HETATM 12 HB3 PCA A 1 -2.418 1.075 9.764 1.00 1.11 H HETATM 13 HG2 PCA A 1 -3.794 3.319 10.907 1.00 1.29 H HETATM 14 HG3 PCA A 1 -3.992 1.597 11.364 1.00 1.54 H